biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Post by SayitLykitizon Jul 07, 2011 9:05pm

395 Views

Post# 18808944

BiOasis spending some $ on promotion...

Did you notice? BioAsis promotional ads (on the left of this screen, as I speak). 2 different placements, in fact.
First time I notice them... so thinking this is new. Nice!
As a side note: was really sorry to see you attacked that way on MDG board, TB. Maybe I'll drop a word of support?

Bullboard Posts

The Market Online’s Weekly Gold Report – Nov. 13, 2024